MedTrace Logo

Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment

NCT02034669 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2014-01-13

No results posted yet for this study

Summary

This study is designed to assess the safety and effect of autologous adipose derived stem cell (ADSCs) transplantation in acute spinal cord injury patients.

1. To assess the safety of autologous ADSCs transplantation in acute spinal cord injury and the complication after ADSCs transplantation.
2. To evaluate the effect of ADSCs isolation and expansion procedure.
3. To determine if functional outcome is improved following ADSCs transplantation in acute spinal cord injury patient, using pre-transplantation spinal cord function as the control.

Conditions

  • Acute Spinal Cord Injury

Interventions

DEVICE

Laminectomy

surgical laminectomy with glial scar resection

DEVICE

Intradural space

ADSCs injection into Intradural space at damage site

DEVICE

Intrathecal

ADSCs Intrathecal into lumbar puncture

DEVICE

Intravenous

ADSCs intravenous

Sponsors & Collaborators

  • Tri Phuoc Biotechnology., JSC

    lead OTHER

Principal Investigators

  • Phuc Ba Duong, MD · Tri Phuoc Biotechnology., JSC

  • Hoa D Nguyen, MD · Vietnamese- German Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-12-31
Completion
2015-03-31

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02034669 on ClinicalTrials.gov